Which abx is prophylacticly given in COPD and who qualifies
Azithro
The patient no longer smokes.
Has optimised non-pharmacological management & inhaled therapies.
Referred to pulmonary rehab (if appropriate).
4 acute exacerbations in the last year (producing sputum), requiring hospital admission at least once.
Asthma classification of severity
Mod- PEFR 50-75% best or predicted
Speech normal
Severe- PEFR 33 - 50% best or predicted
Can’t complete sentences
RR > 25/min
Pulse > 110 bpm
Life threatening- PEFR < 33% best or predicted
Oxygen sats < 92%
‘Normal’ pCO2 (4.6-6.0 kPa)
Silent chest, cyanosis or feeble respiratory effort
Bradycardia, dysrhythmia or hypotension
Exhaustion, confusion or coma
Near fatal- raised CO2
Lights Criteria
Effusion lactate dehydrogenase (LDH) level greater than 2/3 the upper limit of normal serum LDH
Pleural fluid LDH divided by serum LDH >0.6
Pleural fluid protein divided by serum protein >0.5
Indications of placing chest tube with pleural infections
Patients with frankly purulent or turbid/cloudy pleural fluid on sampling should receive prompt pleural space chest tube drainage.
The presence of organisms identified by Gram stain and/or culture from a non-purulent pleural fluid sample indicates that pleural infection is established and should lead to prompt chest tube drainage.
Pleural fluid pH < 7.2 in patients with suspected pleural infection indicates a need for chest tube drainage.
Tests before TB treatment
FBC
LFT
U+E
Vision
Asthma treatment adults
1st- AIR therapy (ICS/LABA) - e.g. Budesonide / Formoterol 100/6, used as-required
2nd- low dose MART
E.g. Budesonide / Formoterol 100/6, regularly
3rd- moderate dose MART
E.g. Budesonide / Formoterol 200/6.
4th
check the fractional exhaled nitric oxide (FeNO) level if available, and the blood eosinophil count
if either of these is raised, refer to a specialist in asthma care
if neither FeNO nor eosinophil count is raised-(LTRA) or a long-acting muscarinic receptor antagonist (LAMA) used in addition to moderate-dose MART
if control has not improved, stop the LTRA or LAMA and start a trial of the alternative medicine (LTRA or LAMA)
Step 5
refer people to a specialist in asthma
COPD mx long term
SABA Or SAMA PRN
Any asthmatic features?
any previous, secure diagnosis of asthma or of atopy
a higher blood eosinophil count - note that NICE recommend a full blood count for all patients as part of the work-up
substantial variation in FEV1 over time (at least 400 ml)
substantial diurnal variation in peak expiratory flow (at least 20%)
Asthmatic features/features suggesting steroid responsiveness
LABA + inhaled corticosteroid (ICS)
if patients remain breathless or have exacerbations offer triple therapy i.e. LAMA + LABA + ICS
if already taking a SAMA, discontinue and switch to a SABA
No asthmatic features
add a long-acting beta2-agonist (LABA) + long-acting muscarinic antagonist (LAMA)
if already taking a SAMA, discontinue and switch to a SABA
COPD vaccines
Annual influenza
One off pneumococcal
Transfer factor and coefficient
TLCO (Transfer factor for carbon monoxide) — measures how well gases transfer from the alveoli into the pulmonary capillary blood.
TLCO reflects:
Alveolar surface area available for gas exchange
Thickness of alveolar-capillary membrane
Pulmonary capillary blood volume
KCO = TLCO / VA
Efficiency of gas transfer per unit of lung volume
Reduced TLCO
Pulmonary fibrosis Thickened alveolar-capillary membrane
Emphysema Loss of alveolar surface area
Pulmonary embolism Reduced perfusion (less capillary blood volume)
Pulmonary hypertension ↓ Blood flow across membrane
Anemia ↓ Hemoglobin → less CO uptake
Conditions causing Increased TLCO
Asthma- Increased pulmonary blood flow + recruitment of capillaries
Pulmonary hemorrhage- CO uptake by intra-alveolar blood
Polycythemia- More hemoglobin available to bind CO
Left-to-right cardiac shunts Increased pulmonary blood volume
Interpreting TLCO and KCO Together
TLCO↓ KCO ↓ Emphysema (↓ surface area and poor efficiency)
TCLO↓KCO ↑ Pulmonary fibrosis (small lung volume but normal perfusion per unit)
TLCO↓ Normal KCO Pulmonary vascular disease (e.g., PE)
Normal TLCO ↑KCO Asthma or obesity (small lungs but normal or increased perfusion)
↑TLCO ↑KCO Pulmonary hemorrhage, polycythemia
Criteria for discharge after asthma attack
Criteria for discharge
been stable on their discharge medication (i.e. no nebulisers or oxygen) for 12-24 hours
inhaler technique checked and recorded
PEF >75% of best or predicted
Management of acute asthma attack
Oh - Oxygen
Shit - Salbutamol
I - Ipratropium
Hate - Hydrocortisone
My - Magnesium
Asthma - Aminophylline
Symptom relief in non CF bronchiectasis
inspiratory muscle training + postural drainage
Severity of COPD
FEV1 > 80% Stage 1 - Mild - symptoms should be present to diagnose COPD in these patients
50-79% Stage 2 - Moderate
30-49% Stage 3 - Severe
< 30% Stage 4 - Very severe
CURB65 score
C Confusion (abbreviated mental test score <= 8/10)
U urea > 7 mmol/L
R Respiration rate >= 30/min
B Blood pressure: systolic <= 90 mmHg and/or diastolic <= 60 mmHg
65 Aged >= 65 years
consider home-based care for patients with a CURB65 score of 0 or 1 - low risk (less than 3% mortality risk)
consider hospital-based care for patients with a CURB65 score of 2 or more - intermediate risk (3-15% mortality risk)
consider intensive care assessment for patients with a CURB65 score of 3 or more - high risk (more than 15% mortality risk)
Differentiating white outs on CXR
Trachea pulled toward the white-out
Pneumonectomy
Complete lung collapse
Trachea central
Consolidation
Pulmonary oedema (usually bilateral)
Mesothelioma
Trachea pushed away from the white-out
Pleural effusion
Diaphragmatic hernia
Large thoracic mass
Organism causing IE of COPD
H Influenza
Active TB mx
Initial phase - first 2 months (RIPE)
Rifampicin
Isoniazid
Pyrazinamide
Ethambutol
Continuation phase - next 4 months
Rifampicin
Isoniazid
Features of Silicosis
Mining occupation, upper zone fibrosis, egg-shell calcification of hilar nodes
Pneumonia in an alcoholic bacteria
Klebsiella
Pathophysiology behind high Ca in squamous cell
High PTHrP
Low PTH
Management of acute bronchitis
consider antibiotic therapy if patients:
are systemically very unwell
have pre-existing co-morbidities
have a CRP of 20-100mg/L (offer delayed prescription) or a CRP >100mg/L (offer antibiotics immediately)